NDC 58602-703 – Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride

Cetirizine Hydrochloride 5 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Film Coated, Extended Release · Oral

Human Otc Drug

Product NDC58602-703

Product details

Brand name
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Generic name
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler
Aurohealth LLC
Dosage form
Tablet, Film Coated, Extended Release
Route
Oral
Marketing category
ANDA · ANDA212409
Marketed since
March 8, 2023
Listing expires
December 31, 2027
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cetirizine hydrochloride and Pseudoephedrine hydrochloride →

Package NDC codes (4)

Package NDCDescriptionSince
58602-703-0912 BLISTER PACK in 1 CARTON (58602-703-09) / 2 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 8, 2023
58602-703-5312 BLISTER PACK in 1 CARTON (58602-703-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 8, 2023
58602-703-752 BLISTER PACK in 1 CARTON (58602-703-75) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 8, 2023
58602-703-764 BLISTER PACK in 1 CARTON (58602-703-76) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 8, 2023

Other Cetirizine hydrochloride and Pseudoephedrine hydrochloride products